Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

1. Dimopoulos, M.A.
2. Stewart, A.K.
3. Masszi, T.
4. Špička, I.
5. Oriol, A.
6. Hájek, R.
7. Rosiñol, L.
8. Siegel, D.
9. Mihaylov, G.G.
10. Goranova-Marinova, V.
11. Rajnics, P.
12. Suvorov, A.
13. Niesvizky, R.
14. Jakubowiak, A.
15. San-Miguel, J.
16. Ludwig, H.
17. Palumbo, A.
18. Obreja, M.
19. Aggarwal, S.
20. Moreau, P.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BJH.14549 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus